C2 Essential tools to improve patient adherence

Wednesday 31 August 2016
Hilton Buenos Aires : Pacifico A, 3 hours

Organised by the FIP Programme Committee and the FIP Special Interest Group on Pharmacokinetics, Pharmacodynamics and Systems Pharmacology

Simultaneous translation in Spanish


 Poor patient adherence with prescribed drug regimens is a major challenge to pharmaceutical care and the design and analysis of clinical trials. In pharmacotherapy, poor adherence can be associated with the emergence of drug resistance, improper changes in dosing or drug selection, and significant bias in interpreting the results of clinical studies. This session will highlight devices and techniques that allow clinical pharmacists to understand and improve patient adherence in clinical practice and drug trials.

Learning objectives

At the conclusion of this knowledge-based session, participants will be able to:

  1. Identify potential sources of patient non-adherence and their implications for pharmacotherapy and medication management
  2. Describe several approaches using new devices and counseling to monitor and influence patient adherence
  3. Describe the role of the clinical pharmacist in implementing new techniques for improving patient adherence
  4. Describe the implications of non-adherence in the design and analysis of clinical trials.


Hartmut Derendorf (University of Florida, USA)



1)      Establishing regional HIV adherence-pharmacology programmes

Charles Maponga (University of Zimbabwe, Zimbabwe)


2)      Paper-based diagnostic device developed to monitor adherence to anticoagulant therapy 

Michael Hegener (University of Cincinnati Winkle College of Pharmacy, USA)

15:50 – 16:10 Coffee/tea break


3)      New developments in monitoring drug dosing: Cornerstone for measurement, analysis and improvement of a patient's adherence to prescribed medication

Hartmut Derendorf (University of Florida, USA)


4)      Wireless networked systems for monitoring adherence

Jonathan Knights (Certara)